Andreas Calatzis: Clot Retraction and Lysis in Viscoelastometry Explained
Andreas Calatzis, Managing Director of Eonis GmbH and Dynabyte GmbH, shared a post on LinkedIn about a recent article by Anikó Smudla et al., published in Diagnostics, adding:
”Our article on ‘physiological lysis’ in viscoelastometry is online.
The article challenges the interpretation of a low maximum lysis in viscoelastometry as ‘hypofibrinolysis’ and attributes this phenomenon to low clot retraction.
This distinction is clinically relevant because fibrinolysis is mediated by plasmatic factors, whereas clot retraction is a cellular, platelet-dependent process.
The article is the first publication using the new Apiro reagents, and the first study from the clinical study program at the Semmelweis University in Budapest.
You find the article using the link, it is open access.”
Title: Is “Physiological Lysis” in Viscoelastometry a Plasmin-Mediated Process?
Authors: Anikó Smudla, Herbert Schöchl, Andreas Calatzis, Csikós Richárd Gergely, János Fazakas
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering